Patient Registry of Intrathecal Ziconotide Management(PRIZM)
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the effectiveness, long-term safety,
tolerability, satisfaction with treatment, and health-related quality of life (HRQoL)
associated with Intrathecal PRIALT use for severe chronic pain of varying etiologies.